Walleye Trading’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,100
| Closed | -$198K | – | 4434 |
|
|
2026
Q1 | $198K | Sell |
9,100
-26,000
| -74% | -$503K | ﹤0.01% | 3127 |
|
|
2025
Q4 | $755K | Buy |
35,100
+14,100
| +67% | +$297K | ﹤0.01% | 2555 |
|
|
2025
Q3 | $405K | Sell |
21,000
-95,300
| -82% | -$1.7M | ﹤0.01% | 2887 |
|
|
2025
Q2 | $1.99M | Buy |
+116,300
| New | +$4.96M | ﹤0.01% | 1730 |
|
|
2025
Q1 | – | Sell |
-4,600
| Closed | -$559K | – | 4681 |
|
|
2024
Q4 | $559K | Sell |
4,600
-13,700
| -75% | -$1.68M | ﹤0.01% | 2559 |
|
|
2024
Q3 | $2.29M | Sell |
18,300
-32,400
| -64% | -$4.48M | ﹤0.01% | 1590 |
|
|
2024
Q2 | $8.01M | Buy |
50,700
+43,000
| +558% | +$5.52M | 0.02% | 795 |
|
|
2024
Q1 | $997K | Sell |
7,700
-8,700
| -53% | -$1.07M | ﹤0.01% | 2252 |
|
|
2023
Q4 | $1.58M | Sell |
16,400
-14,900
| -48% | -$1.43M | ﹤0.01% | 2111 |
|
|
2023
Q3 | $3.79M | Sell |
31,300
-7,500
| -19% | -$848K | 0.01% | 1301 |
|
|
2023
Q2 | $4.44M | Sell |
38,800
-45,200
| -54% | -$5.83M | 0.01% | 1037 |
|
|
2023
Q1 | $11.6M | Buy |
84,000
+28,200
| +51% | +$3.66M | 0.03% | 569 |
|
|
2022
Q4 | $7.23M | Sell |
55,800
-2,700
| -5% | -$313K | 0.02% | 846 |
|
|
2022
Q3 | $6.47M | Buy |
+58,500
| New | +$5.9M | 0.02% | 852 |
|
|
2022
Q1 | – | Sell |
-12,100
| Closed | -$1.09M | – | 5891 |
|
|
2021
Q4 | $1.09M | Buy |
12,100
+4,000
| +49% | +$342K | ﹤0.01% | 2167 |
|
|
2021
Q3 | $749K | Sell |
8,100
-12,100
| -60% | -$932K | ﹤0.01% | 2521 |
|
|
2021
Q2 | $1.57M | Buy |
20,200
+4,400
| +28% | +$334K | 0.01% | 1707 |
|
|
2021
Q1 | $1.18M | Buy |
15,800
+10,500
| +198% | +$969K | 0.01% | 1764 |
|
|
2020
Q4 | $904K | Sell |
5,300
-10,300
| -66% | -$1.53M | ﹤0.01% | 2074 |
|
|
2020
Q3 | $2.19M | Buy |
15,600
+1,500
| +11% | +$228K | 0.01% | 1059 |
|
|
2020
Q2 | $2.26M | Buy |
14,100
+1,400
| +11% | +$191K | 0.01% | 1002 |
|
|
2020
Q1 | $1.24M | Sell |
12,700
-93,600
| -88% | -$10.7M | 0.01% | 1151 |
|
|
2019
Q4 | $13.7M | Buy |
106,300
+100,000
| +1,587% | +$10.1M | 0.09% | 194 |
|
|
2019
Q3 | $475K | Buy |
6,300
+6,000
| +2,000% | +$709K | ﹤0.01% | 2197 |
|
|
2019
Q2 | $46K | Sell |
300
-900
| -75% | -$109K | ﹤0.01% | 3570 |
|
|
2019
Q1 | $143K | Sell |
1,200
-2,900
| -71% | -$373K | ﹤0.01% | 3266 |
|
|
2018
Q4 | $447K | Buy |
4,100
+1,500
| +58% | +$188K | ﹤0.01% | 2584 |
|
|
2018
Q3 | $420K | Buy |
2,600
+1,800
| +225% | +$246K | ﹤0.01% | 3079 |
|
|
2018
Q2 | $106K | Buy |
+800
| New | +$75.4K | ﹤0.01% | 4017 |
|
|
2016
Q4 | – | Sell |
-4,000
| Closed | -$246K | – | 5157 |
|
|
2016
Q3 | $246K | Buy |
+4,000
| New | +$121K | ﹤0.01% | 2660 |
|
Other funds holding SRPT
EAM
Walleye Trading's SRPT Position: Q2 2026 in Review
Walleye Trading sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 3,259 shares — an estimated $70.9K sold.
Walleye Trading first reported a position in SRPT in Q2 2016 and held it in 22 quarters. The position peaked at $3.8M in Q4 2023. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Walleye Trading reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 3,259 Sarepta Therapeutics shares in Q2 2026, an estimated $70.9K.
- Walleye Trading first reported a position in Sarepta Therapeutics in Q2 2016 and held it in 22 quarters.
- Walleye Trading's Sarepta Therapeutics position peaked at $3.8M in Q4 2023.
- 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.